Indeed, mice with adipose-specific loss of the mTORC1 are lean and resistant to HFD-induced obesity [39], while chronic pharmacological inhibition of mTOR by its specific inhibitor rapamycin exhibited anti-obesity effects in HFD mice [40]. This evidence concerns the gene MTOR and obesity disorder.